Biomea Fusion Inc. (BMEA) stock is expected to see a potential squeeze in the coming weeks, with a 45% short interest according to Fintel. The stock is currently trading at $20 and is predicted to reach $15. A recent article from Zacks highlights the surge in BMEA stock. Additionally, the company has announced the achievement of minimal residual disease negativity in its first complete response, as reported by Marketscreener. Investors are advised against shorting low float stocks like BMEA, especially in the biotech sector, as they can experience extreme movements and create massive buying pressure when shares need to be bought back. The stock is currently going green and buyers are reacting positively to the news.

BMEA stock price is 10.47. BMEA 52 Week low is 8.13. BMEA 52 Week high is 43.69. BMEA 200 day moving average is 15.04. It is currently trading below 200 day moving average. BMEA 50 day moving average is 14.9 which is above(bearish) the current price. RSI (relative strength index) of BMEA is 30.489 which is below (bearish) 70. Chaikin money flow (20 day) of BMEA is -0.202 which is below (bearish) 0.